Fig. 1From: Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introductionTrial flow. *In trial 1 the four cases lost to follow-up at d28 include one P. vivax infection at d28Back to article page